Menu

19.02.2025

CPNN+ Neurofeedback Workshop

19th & 20th June 2025. University of Glasgow. Registration is now open!

CPNN+ Neurofeedback Workshop

2 day interactive hybrid workshop

Thursday 19th & Friday 20th June 2025

Advanced Research Centre – University of Glasgow https://www.gla.ac.uk/research/arc/

To register your place, please complete our online registration form here by 30th April 2025: https://forms.office.com/e/82FQyyQzzX, or scan our QR code below

Workshop Aims

  • An interdisciplinary workshop that aims to explore the theoretical and practical aspects of neurofeedback with a focus on its application on pain treatment.
  • There will be morning talks across a range of translational topics that will cover neurofeedback in invasive and non invasive experimental human models, methodological considerations and clinical studies. Ethical aspect of using neurotechnology and its placebo effect will also be discussed.
  • Afternoon interactive workshops will focus on how to design and implement EEG based neurofeedback and introduction to real time fMRI with a demonstration of its experimental setup

Details

Open to all, and aimed at early career researchers, our ‘Neurofeedback’ workshop will include up to 6 talks from various guest speakers each morning, a workshop each afternoon, poster presentations over lunchtime and dinner (free of charge) on the first evening.

Overnight accommodation will also be included, should you require this.

This event is hybrid, and open to delegates wishing to join online for the guest speaker talks only.

There will also be dedicated space at our venue to allow for networking and/or to continue with any work/meeting commitments.

Please note that spaces are limited so we encourage you to express your interest & register as soon as possible.

If you do not wish to be photographed at this event, please let us know via your registration form.

Agenda

Thursday 19th June 2025

  • 9.30am – Markus Ploner – ‘EEG-based neurofeedback for modulating pain – Evidence from a Registered Report’
  • 10.00am – Rachel Crockett – ‘Putting the Patient in the Driving Seat: Neurofeedback for Central Post-Stroke Pain Patients with Deep Brain Stimulation’
  • 10.30am – Andrew Jackson – ‘Closed-loop neuromodulation: from optogenetics to music’
  • 11.00am – Coffee break
  • 11.30am – Damien Coyle – NeuroCONCISE and wearable Neurotechnologies (title TBC)
  • 12.00pm – Ioana Susnoschi Luca – ‘Scaling Neurofeedback for Greater Clinical Impact – a trip to Singapore’
  • 12.30pm – Lars Williams – ‘How might neurotechnology fit into the messy reality of a secondary care chronic pain service? A clinician’s perspective’
  • 1.00pm – Lunch
  • 2.00pm – Afternoon workshop – hands on EEG neurofeedback & equipment demonstration, including demonstrations from NeuroCONCISE
  • 7.30pm – Dinner located at One A The Square, Gilbert Scott Building, University of Glasgow

Friday 20th June 2025

  • 9.30am – Sylvia Gustin – ‘EEG-Based Neuromodulation for Neuropathic Pain After Spinal Cord Injury: Targeting the Brain for Better Outcomes’ (online presentation)
  • 10.00am – Ben Seymour – fMRI Neurofeedback (title TBC)
  • 10.30am – Sarah Chan – Bioethics (title TBC)
  • 11.00am – Coffee break
  • 11.30am – TBC
  • 12.00pm – Ulrike Bingel – ‘Mechanisms and implications of placebo and nocebo effects’ (online presentation)
  • 12.30pm – Innovate UK KTN (title TBC)
  • 1.00pm – Lunch
  • 2.00pm – Afternoon workshop (full details TBC), including demonstrations from BrainTrainUK

Please note that all posters will be displayed in the break areas over both days.

Guest Speaker Bio’s

(in order of presenting)

Markus Ploner is a Professor of Human Pain Research and Head of the Interdisciplinary Center for Pain Medicine at the Technical University of Munich. A neurologist and pain researcher, he investigates the brain mechanisms of pain, focusing on brain oscillations, connectivity, and neuromodulation, including neurofeedback. His interdisciplinary work bridges experimental and clinical research through rigorous, evidence-based approaches, including registered reports. His ultimate goal is to develop biomarkers and novel treatment strategies to improve pain management.

Rachel Crockett received her PhD in Rehabilitation Sciences from the University of British Columbia. She then joined Prof. Helen Brontë-Stewart at Stanford University, where she used diverse neuroimaging methodologies to evaluate novel targets for deep brain stimulation in people with Parkinson’s Disease. Since October 2023, Rachel has been working under the supervision of Profs Tim Denison and Ben Seymour at the University of Oxford. Her current work investigates the use of neuromodulation and neurofeedback techniques to treat chronic pain.

Andrew Jackson is Professor of Neural Interfaces and Co-Director of the Centre for Translational Neuroscience at Newcastle University. His research interests focus on bidirectional, closed-loop neural interfaces for the restoration and augmentation of brain circuitry. He has co-founded two early-stage neurotechnology companies, MintNeuro Ltd and Neudio Inc, and helps lead the EPSRC/MRC-funded Closed-loop Neural Interfaces Technologies (CloseNIT) Network.

Damien Coyle (TBC)

Ioana Susnoschi Luca is a postdoctoral researcher at the Centre for Rehabilitation Engineering, University of Glasgow, where she works on a clinical trial investigating neurofeedback for pain reduction in individuals with fibromyalgia and rheumatoid arthritis. Ioana is passionate about advancing neurorehabilitation strategies by facilitating knowledge transfer of neurotechnologies, bridging the gap between innovation and clinical practice to improve patient outcomes.

Dr Lars Williams has worked for NHS Greater Glasgow & Clyde as a Consultant in Anaesthesia and Pain Medicine for 20 years, full time in pain medicine for the last 10 years. His clinical work includes providing medical input to the Scottish National Pain Management Programme (PMP), outpatient clinics and theatre work, mostly RF denervation procedures for spinal pain. He has developed a secondary care mindfulness program for chronic pain, as well as multi-disciplinary assessment clinics for patients with complex psychosocial needs. He chairs the Glasgow Managed Care Network (MCN) Primary Care interface group and is the National Lead for the Scottish Pain Medics Network. He is currently working with the Scottish Health Technologies Group (SHTG), developing recommendations on specialist interventions for managing chronic non-malignant pain in adults. He has published on mindfulness in chronic pain, and the effects of social deprivation on participation in PMPs. He is an Honorary Clinical Senior Lecturer at Glasgow University School of Medicine.

Prof. Sylvia Gustin is the Director of the Centre for Pain IMPACT at Neuroscience Research Australia (NeuRA), where she leads an interdisciplinary team of 82 researchers and clinicians dedicated to advancing chronic pain management. She is also the Director of the NeuroRecovery Research Hub at the University of New South Wales, a Rebecca L. Cooper Research Fellow, and a Senior Principal Research Scientist at NeuRA. In addition, Prof. Gustin chairs the ENIGMA Chronic Pain Working Group, contributing her expertise to large-scale neuroimaging initiatives worldwide.

Sylvia completed her Ph.D. at the University of Tübingen, Germany, in 2006 and relocated to Australia in 2007. Since then, she has been using multimodal brain imaging techniques and psychological assessment to investigate the neural and psychological mechanisms of chronic pain, with a special focus on neuropathic pain following spinal cord injury. Her program of research forms a translational pipeline where her basic science research informs the development of novel brain technology and digital interventions that are translated to improve the lives of people with chronic pain.

Sylvia’s research is supported by the Australian National Health and Medical Research Council (NHMRC), the Medical Research Future Fund (MRFF), Rebecca L. Cooper Medical Research Foundation, International Association for the Study of Pain (IASP), Wings for Life, US Department of Defence (DoD), NSW Defence Innovation Network and NSW Health.

Prof. Ben Seymour is a Wellcome Senior Clinical Fellow working jointly at the Wellcome Centre for Integrative Neuroimaging and the Oxford Institute for Biomedical Engineering. He is also a Fellow at the Alan Turing Institute and an honorary consultant neurologist at the John Radcliffe Hospital. Ben’s lab addresses the computational and systems neuroscience of pain: building realistic models of neuronal information processes to understand pain perception and behaviour, and testing these theories using a range of experimental methodologies. The ultimate goal is to develop new technology-based therapies for treating pain in clinical populations

Dr Sarah Chan is a Reader in Bioethics at the Usher Institute, University of Edinburgh and an Associate Director of the Centre for Biomedicine, Self and Society. Previously, from 2005 to 2015, she was a Research Fellow in Bioethics at the University of Manchester, first at the Centre for Social Ethics and Policy and from 2008 the Institute for Science Ethics and Innovation. Sarah’s research focuses on the ethics of new biomedical technologies, including gene therapy and genetic modification; stem cell and embryo research; reproductive medicine; synthetic biology; and human and animal enhancement. Her current work draws on these interests to explore the ethics of emerging modes of biomedicine at the interface of health care research, medical treatment and consumer medicine, including genetics and neurotechnologies; ‘’big data’ and artificial intelligence; the use of human biomaterials in both research and treatment; and access to experimental treatments and medical innovation.

Ulrike Bingel, a neurologist and Professor of Clinical Neuroscience heads the Interdisciplinary Center for Pain Medicine and Translational Pain Research at University Medicine Essen. Her interdisciplinary research group focuses on the interactions between pain and cognition. Her research addresses the CNS mechanisms underlying nociception, pain, and pain modulation in health and disease using scientific methods that range from pharmacological MRI to clinical studies. Translation to treatment inspires her work on placebo and nocebo effects and their contribution to health and treatment outcomes. As speaker of the collaborative research center “Treatment Expectations“, funded by the German Research Foundation and Vice Dean for Research at the Medical Faculty, she is dedicated to fostering national and international collaboration, building support structures for the next generation of scientists, and communicating scientific knowledge to patients and the public.

Innovate UK KTN (TBC)

Prof. Frank Pollick (TBC)

BrainTrainUK (TBC)

Contact

For any queries, please do not hesitate to contact our research network coordinator – abigail.stuart@ndcn.ox.ac.uk

We look forward to welcoming you!